Use of PAK inhibitor for the treatment of a joint disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8187828
APP PUB NO 20090104279A1
SERIAL NO

12055511

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention refers to the use of a p21-activated kinase (PAK) inhibitor as a target protein for the discovery of a PAK inhibitor as a medicament for the treatment of a joint disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI-AVENTIS DEUTSCHLAND GMBHBRUNINGSTRASSE 50 FRANKFURT AM MAIN D-65929

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barradeau, Sebastian Paris, FR 3 0
Bartnik, Eckart Wiesbaden, DE 21 358
Czech, Joerg Marburg, DE 11 42
Klatt, Andreas R Cologne, DE 3 0
Leberer, Ekkehard Germering, DE 11 5
Leeuw, Thomas Greifenberg, DE 12 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation